0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug/Vaccine Safety
 41-60 of 101 Articles
Editor's Correspondence | 
Lee Cantrell, PharmD; Jeffrey Suchard, MD; Roy Gerona, PhD
JAMA Intern Med. 2013;173(11):1034-1035. doi:10.1001/jamainternmed.2013.832.

Editor's Correspondence | 
Michael M. Madden, PhD; Frank M. Etzler, PhD; Thomas Gant, PhD
JAMA Intern Med. 2013;173(11):1034-1035. doi:10.1001/jamainternmed.2013.409.

Special Article | 
Peter Doshi, PhD
JAMA Intern Med. 2013;173(11):1014-1016. doi:10.1001/jamainternmed.2013.490.
Includes: CME

Invited Commentary | 
Eleni Linos, MD, DrPH
JAMA Intern Med. 2013;173(10):920-937. doi:10.1001/jamainternmed.2013.743.

Research Letters |  FREE
Gilles Safa, MD; Laure Darrieux, MD
JAMA Intern Med. 2013;173(10):924-926. doi:10.1001/jamainternmed.2013.374.

Research Letters |  FREE
Sengwee Toh, ScD; Meghan A. Baker, MD, ScD; Jeffrey S. Brown, PhD; et al.
JAMA Intern Med. 2013;173(9):817-819. doi:10.1001/jamainternmed.2013.3004.
Includes: Supplemental Content

Original Investigation |  FREE
Sarah D. Berry, MD, MPH; Yoojin Lee, MS, MPH; Shubing Cai, PhD; et al.
JAMA Intern Med. 2013;173(9):754-761. doi:10.1001/jamainternmed.2013.3795.

Viewpoint | 
Staffan Svensson, MD, PhD; David B. Menkes, MD, PhD; Joel Lexchin, MSc, MD
JAMA Intern Med. 2013;173(8):611-612. doi:10.1001/jamainternmed.2013.3037.
Includes: Supplemental Content

Commentary | 
Robert Steinbrook, MD
JAMA Intern Med. 2013;173(5):373-374. doi:10.1001/jamainternmed.2013.3842.

Editorial | 
Mitchell H. Katz, MD
JAMA Intern Med. 2013;173(3):178. doi:10.1001/jamainternmed.2013.1838.

Special Article | 
Jonas B. Green, MD, MPH, MSHS; Joseph S. Ross, MD, MHS; Cynthia A. Jackevicius, PharmD, MSc; et al.
JAMA Intern Med. 2013;173(3):229-232. doi:10.1001/jamainternmed.2013.1529.

Editor's Correspondence | 
Vinay Prasad, MD; Jason Rho, MD; Adam Cifu, MD
Arch Intern Med. 2012;172(21):1692-1693. doi:10.1001/2013.jamainternmed.206.

Research Letters |  FREE
Joel Lexchin, MSc, MD
Arch Intern Med. 2012;172(21):1680-1681. doi:10.1001/archinternmed.2012.4444.

Invited Commentary | 
Thomas J. Moore, AB
Arch Intern Med. 2012;172(21):1681-1682. doi:10.1001/2013.jamainternmed.610.

Editor's Correspondence | 
Sébastien Champion, MD; Bernard Alex Gaüzère, MD; Yannick Lefor, MD
Arch Intern Med. 2012;172(20):1613-1614. doi:10.1001/archinternmed.2012.4418.

Research Letters |  FREE
Abeer Ahmad, MSc; Giel Nijpels, MD, PhD; Jacqueline M. Dekker, PhD; et al.
Arch Intern Med. 2012;172(17):1346-1347. doi:10.1001/archinternmed.2012.2816.

Editor's Correspondence | 
Arch Intern Med. 2012;172(9):747-748. doi:10.1001/archinternmed.2012.1297.

Editor's Correspondence | 
Arch Intern Med. 2012;172(9):747-748. doi:10.1001/archinternmed.2012.1035.

Research Letters |  FREE
Thomas J. Moore, AB; Sonal Singh, MD, MPH; Curt D. Furberg, MD, PhD
Arch Intern Med. 2012;172(1):78-80. doi:10.1001/archinternmed.2011.618.
Includes: Supplemental Content

Research Letters |  FREE
Abbey Powers, PharmD; G. Elliott Cook, PharmD, BCPS
Arch Intern Med. 2012;172(1):72-73. doi:10.1001/archinternmed.2011.525.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA
Review  | 
Treatment of Hepatitis C:  A Systematic Review
Anita Kohli, MD, MS; Ashton Shaffer, BA; Amy Sherman, MD; et al.
JAMA
Original Investigation  | 
Genetic Variants Associated With Phenytoin-Related Severe Cutaneous Adverse Reactions
Wen-Hung Chung, MD, PhD; Wan-Chun Chang, MS; Yun-Shien Lee, PhD; et al.
JAMA Dermatology
Research Letter  | 
Risk for Nevus Transformation and Melanoma Proliferation and Invasion During Natalizumab Treatment:  Four Years of Dermoscopic Follow-up With Immunohistological Studies and Proliferation and Invasion Assays
Momen Pharaon, MD; Mélanie Tichet, MSc; Christine Lebrun-Frénay, MD, PhD; et al.
JAMA Ophthalmology
Original Investigation  | 
Combined Intravitreal Melphalan and Topotecan for Refractory or Recurrent Vitreous Seeding From Retinoblastoma
Fariba Ghassemi, MD; Carol L. Shields, MD; Hadi Ghadimi, MD; et al.